AAPL   323.34 (+0.46%)
MSFT   184.91 (+1.14%)
FB   232.72 (+0.35%)
GOOGL   1,442.31 (+0.52%)
AMZN   2,472.41 (+0.06%)
NVDA   353.01 (+0.22%)
CGC   16.14 (-2.06%)
BABA   214.33 (+3.76%)
MU   46.82 (+1.04%)
GE   7.05 (+4.29%)
TSLA   881.56 (-1.84%)
AMD   53.54 (-0.17%)
T   30.99 (+0.19%)
ACB   14.53 (+3.05%)
F   5.90 (+0.51%)
GILD   73.26 (-2.53%)
DIS   118.75 (-0.02%)
NFLX   427.31 (+0.33%)
BAC   24.84 (+0.93%)
BA   153.31 (+1.27%)
AAPL   323.34 (+0.46%)
MSFT   184.91 (+1.14%)
FB   232.72 (+0.35%)
GOOGL   1,442.31 (+0.52%)
AMZN   2,472.41 (+0.06%)
NVDA   353.01 (+0.22%)
CGC   16.14 (-2.06%)
BABA   214.33 (+3.76%)
MU   46.82 (+1.04%)
GE   7.05 (+4.29%)
TSLA   881.56 (-1.84%)
AMD   53.54 (-0.17%)
T   30.99 (+0.19%)
ACB   14.53 (+3.05%)
F   5.90 (+0.51%)
GILD   73.26 (-2.53%)
DIS   118.75 (-0.02%)
NFLX   427.31 (+0.33%)
BAC   24.84 (+0.93%)
BA   153.31 (+1.27%)
AAPL   323.34 (+0.46%)
MSFT   184.91 (+1.14%)
FB   232.72 (+0.35%)
GOOGL   1,442.31 (+0.52%)
AMZN   2,472.41 (+0.06%)
NVDA   353.01 (+0.22%)
CGC   16.14 (-2.06%)
BABA   214.33 (+3.76%)
MU   46.82 (+1.04%)
GE   7.05 (+4.29%)
TSLA   881.56 (-1.84%)
AMD   53.54 (-0.17%)
T   30.99 (+0.19%)
ACB   14.53 (+3.05%)
F   5.90 (+0.51%)
GILD   73.26 (-2.53%)
DIS   118.75 (-0.02%)
NFLX   427.31 (+0.33%)
BAC   24.84 (+0.93%)
BA   153.31 (+1.27%)
AAPL   323.34 (+0.46%)
MSFT   184.91 (+1.14%)
FB   232.72 (+0.35%)
GOOGL   1,442.31 (+0.52%)
AMZN   2,472.41 (+0.06%)
NVDA   353.01 (+0.22%)
CGC   16.14 (-2.06%)
BABA   214.33 (+3.76%)
MU   46.82 (+1.04%)
GE   7.05 (+4.29%)
TSLA   881.56 (-1.84%)
AMD   53.54 (-0.17%)
T   30.99 (+0.19%)
ACB   14.53 (+3.05%)
F   5.90 (+0.51%)
GILD   73.26 (-2.53%)
DIS   118.75 (-0.02%)
NFLX   427.31 (+0.33%)
BAC   24.84 (+0.93%)
BA   153.31 (+1.27%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 PPDAgios PharmaceuticalsAmicus TherapeuticsDeciphera PharmaceuticalsTaro Pharmaceutical Industries
SymbolNASDAQ:SDGRNASDAQ:AGIONASDAQ:FOLDNASDAQ:DCPHNYSE:TARO
Price Information
Current Price$69.60$52.29$13.14$59.32$68.40
52 Week RangeHoldBuyBuyBuyBuy
Beat the Market™ Rank
Overall Score0.91.71.41.51.4
Analysis Score1.24.43.43.43.5
Community Score2.62.73.02.52.2
Dividend Score0.00.00.00.00.0
Ownership Score0.01.00.01.00.0
Earnings & Valuation Score0.60.60.60.61.3
Analyst Ratings
Consensus RecommendationHoldBuyBuyBuyBuy
Consensus Price Target$59.67$66.20$20.50$68.06$96.00
% Upside from Price Target-14.27% downside26.60% upside56.01% upside14.74% upside40.35% upside
Trade Information
Market Cap$4.33 billion$3.59 billion$3.26 billion$3.39 billion$2.61 billion
BetaN/A2.141.292.190.8
Average Volume1,338,079728,2473,319,100581,27344,857
Sales & Book Value
Annual RevenueN/A$117.91 million$182.24 million$25 million$644.77 million
Price / SalesN/A30.5518.58132.544.06
CashflowN/AN/AN/AN/A$6.97 per share
Price / CashN/AN/AN/AN/A9.81
Book ValueN/A$10.88 per share$1.87 per share$10.71 per share$55.15 per share
Price / BookN/A4.817.035.541.24
Profitability
Net IncomeN/A$-411,470,000.00$-356,390,000.00$-192,260,000.00$244.24 million
EPSN/A($6.86)($1.31)($4.48)$6.35
Trailing P/E Ratio0.00N/AN/AN/A10.75
Forward P/E RatioN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/A-205.20%-155.73%N/A37.88%
Return on Equity (ROE)N/A-63.85%-63.24%-42.53%11.94%
Return on Assets (ROA)N/A-45.21%-37.83%-38.44%10.79%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A0.17%0.50%0.02%N/A
Current RatioN/A8.41%4.45%15.61%6.88%
Quick RatioN/A8.27%4.31%15.61%6.19%
Ownership Information
Institutional Ownership Percentage34.90%97.73%N/A71.97%11.60%
Insider Ownership PercentageN/A3.16%2.30%3.81%13.80%
Miscellaneous
Employees3924825081121,464
Shares Outstanding63.30 million68.89 million257.66 million55.86 million38.26 million
Next Earnings Date8/12/2020 (Estimated)8/6/2020 (Estimated)8/13/2020 (Estimated)8/7/2020 (Estimated)8/13/2020 (Estimated)
OptionableNot OptionableOptionableOptionableOptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.